Publications
- Notes to the pathophysiology of myelodysplastic syndrome, demethylation therapy and the role of cytokine-induced differentiation2013 | First Faculty of Medicine
- Myelodysplastic syndromes – therapy progress over the last two decades2013 | First Faculty of Medicine
- Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II2013 | First Faculty of Medicine
- Immunomodulation therapy - lenalidomide in the treatment of myelodysplastic syndrome in low-risk groups with deletion of the long arm of chromosome 52013 | First Faculty of Medicine
- Principles of treatment of patients with early forms of myelodysplastic syndrome2013 | First Faculty of Medicine
- Current recommendations in chelation therapy2013 | First Faculty of Medicine
- Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports2012 | First Faculty of Medicine
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- New medical technologies help patients with MDS2012 | First Faculty of Medicine
- Iron overload in patients receiving frequent blood transfusions and its therapy2012 | First Faculty of Medicine
Loading network view...
